Pharmaceutical Business review

Lonza to expand Singapore manufacturing plant

The expansion will add 1858m² of space and associated equipment and support cell line construction, upstream and downstream process development, and a range of analytical services.

The expanded facility expects to offer customers a range of services from development through pre-clinical and small-scale manufacturing, to large-scale commercial supply.

Lonza Development Services head Janet White said they are looking forward to offering the full range of GS Gene Expression System and other technologies in Asia.

Exit mobile version